KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Treasury Shares: 2009-2025

Historic Treasury Shares for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Sep 2025 value amounting to $106.0 million.

  • Teva Pharmaceutical Industries' Treasury Shares changed negligibly% to $106.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $107.0 million for FY2024, which is 0.94% up from last year.
  • Teva Pharmaceutical Industries' Treasury Shares amounted to $4.1 billion in Q3 2025, which was down 0.00% from $4.1 billion recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Treasury Shares registered a high of $107.0 million during Q4 2024, and its lowest value of $24.4 million during Q4 2021.
  • For the 3-year period, Teva Pharmaceutical Industries' Treasury Shares averaged around $4.1 billion, with its median value being $4.1 billion (2025).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Treasury Shares declined by 0.93% in 2021 and then surged by 228.15% in 2023.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Treasury Shares stood at $4.1 billion in 2021, then remained steady at $4.1 billion in 2022, then remained steady at $4.1 billion in 2023, then remained steady at $4.1 billion in 2024, then remained steady at $4.1 billion in 2025.
  • Its Treasury Shares stands at $106.0 million for Q3 2025, versus $106.0 million for Q2 2025 and $106.0 million for Q1 2025.